PCRBF(PCRBF)
PCRBF
No analyst ratings available
No analyst price targets available for PCRBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.08B | $2.16B | $2.26B |
| Low | $2.08B | $2.16B | $2.26B |
| High | $2.08B | $2.16B | $2.26B |
| EBITDA Avg | $132M | $137M | $144M |
| Low | $132M | $137M | $144M |
| High | $132M | $137M | $144M |
| EBIT Avg | $71M | $74M | $77M |
| Low | $71M | $74M | $77M |
| High | $71M | $74M | $77M |
| Net Income Avg | $42M | $51M | $60M |
| Low | $42M | $51M | $60M |
| High | $42M | $51M | $60M |
| EPS Avg | $0.26 | $0.31 | $0.37 |
| Low | $0.26 | $0.31 | $0.37 |
| High | $0.26 | $0.31 | $0.37 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $573M | $581M | $443M |
| Low | $573M | $581M | $443M |
| High | $573M | $581M | $443M |
| EBITDA Avg | $36M | $37M | $28M |
| Low | $36M | $37M | $28M |
| High | $36M | $37M | $28M |
| EBIT Avg | $20M | $20M | $15M |
| Low | $20M | $20M | $15M |
| High | $20M | $20M | $15M |
| Net Income Avg | $25M | $18M | $-7M |
| Low | $25M | $18M | $-7M |
| High | $25M | $18M | $-7M |
| EPS Avg | $0.15 | $0.11 | $-0.04 |
| Low | $0.15 | $0.11 | $-0.04 |
| High | $0.15 | $0.11 | $-0.04 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |